Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeu

PHILADELPHIA, March 24, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. :Grabar Law Office is investigating whether certain officers and directors of Akero breached their fiduciary duties owed to the company.If you have held Akero Therapeutics, In